@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix RNA: . @prefix hgnc: . @prefix geneProductOf: . @prefix atcc: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:217; a RNA: . sub:_2 occursIn: atcc:CRL-1573.aspx, species:9606; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject schem:Colforsin; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:Colforsin) -> r(HGNC:ADAMTS1)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "Supporting Table 7. The lists of cAMP responsive genes from HEK293T and MIN6 cells, hepatocytes, and pancreatic islets based on gene profiling using Affymetrix arrays. The values are lower bounds of the 90% confidence intervals of fold changes. In other words, if the lower bound value is 1, one can say with 90% probability that the gene expression is increased (fold change ³ 1). Gene expression induced by cAMP treatment (forskolin) is shown in \\\"FSK induction\\\" columns; inhibition by dominant negative A-CREB is shown in \\\"A-CREB inhibition\\\" columns. "; prov:wasQuotedFrom pubmed:15753290 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:15753290; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:33.289+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }